Background: The aim of the study was to evaluate the toxicokinetics of 2-methylnaphtalene (2-MN) during and after inhalation exposure. Material and Methods: Male Wistar rats were exposed to 2-MN vapours at nominal concentrations of 200 or 400 mg/m 3 in the dynamic inhalation chamber for 6 hours or 5 days (6 h/day). Blood samples were collected during and after exposure. Blood concentrations of 2-MN were estimated by gas chromatography using the headspace technique. Results: During a 6-hour exposure to 200 or 400 mg/m 3 , blood 2-MN concentration increased rapidly within the first or second hour of exposure, respectively, after reaching a plateau. The elimination of 2-MN from blood followed an open twocompartment model. Conclusion: 2-MN was rapidly eliminated from blood of the animals exposed by inhalation to 2-MN. During exposure, lung retention of the chemical was found to decrease. Under conditions of repeated 2-MN exposure, no significant systemic 2-MN accumulation could be observed.
INTRODUCTION

2-Methylnaphtalene (2-MN) is a petrol component and it
can also be found in numerous commercial solvent mixtures [1, 2] . 2-MN is one of the many constituents of tobacco smoke [3] . Human systemic 2-MN penetration is attributable primarily to inhalation exposure. Only a few reports assessing 2-MN toxicity in humans or animals under conditions of inhalation exposure are available in literature [4] .
Studies on mice have shown that the major toxic effect of 2-MN is on the lungs, and there has been a strong correlation between 2-MN dose and lung damage [5] [6] [7] . Animal inhalation study revealed that a single dose of 2-MN produced a strong irritant effect in mice and a neurotoxic effect in rats [8] .
The present paper discusses the toxicokinetics of 2-MN in rat blood under conditions of single or repeated exposure to 2-MN.
MATERIALS AND METHODS
Chemicals
2-Methylnaphtalene (2-MN, CAS
No.: 91-57-6) was supplied by Fluka. Its chemical purity was 97%.
Animals and inhalation exposure
Male Wistar IMP: WIST rats weighing 290-380 g (3-4 months old) were exposed to 2-MN vapours at the target concentrations of 200 and 400 mg/m 3 in the dynamic inhalation chamber (volume 0.25 m 3 , 15 air changes per hour) for 6 hours or 5 consecutive days (6 hours/day). The animals were given standard laboratory food and water ad libitum, except for the time when they were exposed to 2-MN vapours. The relative temperature in the chamber was maintained at 20-22°C and humidity at 40-50%. The required 2-MN vapours were generated by heating 2-MN to 85°C in a glass washer. The desired vapour concentrations were obtained through air dilution. Vapour sample (0.5 dm Figure 2 and Table 2 . A rapid decrease in blood 2-MN levels was noted within the first hour after a single exposure to low 2-MN levels. In the animals exposed to high 2-MN concentrations, this process was noted during the first two hours of observation. During (ethyl alcohol from Polmos, Poland; purity 95%). The concentration of 2-MN vapours in the exposure chamber was measured every 30 min by gas chromatography (HewlettPackard 5890) with a flame ionisation detector (FID) using capillary column (HP-1; 5 m, 0.53 mm, 2.65 μm film thickness). The operating conditions were: carrier gashelium, column flow 10 ml/min; make-up gas (helium) 20 ml/min; air 300 ml/min; oven 150°C; inlet split 220°C, detector 230°C.
Biological material collection and analysis
Venous blood samples drawn from the tail vein were collected before (0 h), during (1, 2, 3, 4, 5, 6 h) and after (0.05, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 6 h) exposure to 2-MN vapours into 100 μl heparinized glass capillary. The collected samples were stored at +5°C until the determination. Blood 2-MN concentrations were estimated by gas chromatography combined with the headspace technique, using naphthalene as an internal standard [9]. Gas chromatograph (Hewlett-Packard 5890 Series II) was equipped with FID. The operating temperature of the capillary column (HP-1; 30 m, 0.53 mm, 2.65 μm film thickness) was 150°C. The operating conditions were: carrier gashelium, constant flow mode, column flow 10 ml/min; make-up gas (helium) 20 ml/min; air 300 ml/min; inlet split 220°C, detector 240°C. The limit of detection for 2-MN was 0.01 mg/l for blood analysis.
Statistical analysis
An open two-compartment model plotted with SigmaPlot 4.0 for Windows (Jandel Corporation) was used for the kinetic analysis of 2-MN in blood. The differences in 2-MN blood concentrations between the days of exposure were estimated using Student t-test [10]. P < 0.05 was considered significant.
RESULTS
2-MN concentrations in rat blood during a six-hour inhalation exposure to 2-MN vapours at the nominal concentrations of 200 or 400 mg/m 3 and the elimination kinetics data are presented in Figure 1 and Table 1 . During a six- Results are presented as mean ±SD, six animals per group. concentrations affected the calculated AUC values. After repeated exposure to 2-MN, the AUC was almost three times as high as that after a single exposure. Two major factors may have accounted for the increase in the AUC value and blood 2-MN concentration in the repeatedly exposed rats. The first one was the difference in the magnitude of exposure to 2-MN during a single and repeated exposure. The mean concentration of 2-MN under conditions of repeated exposure was ca. 15% higher than that during a single exposure. The other factor was the high affinity of 2-MN to the kidney, liver and adipose tissue [6] . The particularly high 2-MN affinity to the liver and kidney, belonging to the rapidly equilibrating compartments, could affect 2-MN distribution and elimination in the rats repeatedly exposed to 2-MN, which has resulted in higher blood 2-MN levels and greater AUC value. The animals repeatedly exposed to high 2-MN concentrations showed decreased blood 2-MN levels on the consecutive days after the daily 6-hour period of exposure ( Figure 3 ). This has resulted in shorter half-lives of elimination (phase I and II) and a lower AUC value compared with a single-dose exposure (Tables 2 and 3 ). The underlying factors include lower lung retention of 2-MN in the rats exposed to higher 2-MN concentrations, as well as faster 2-MN metabolism and quicker 2-MN removal attributable to the high 2-MN affinity to the kidney [6] .
To sum up, 2-MN was rapidly eliminated from the blood of animals subjected to inhalation exposure. Under conditions of inhalation exposure to 2-MN, lung retention of the chemical decreased. In repeated exposure, no significant systemic 2-MN accumulation in the rats could be observed. in phase I of 2-MN elimination from blood were similar and did not depend on the magnitude of exposure. After repeated exposure to 2-MN, the half-lives in phase II and the AUC value evidently increased with an increasing 2-MN concentration.
DISCUSSION AND CONCLUSIONS
A rapid increase in blood 2-MN concentration during the first hours of exposure was noted in the animals exposed by inhalation to different levels of 2-MN ( Figure 1 ). In guinea pigs, a quick penetration of 2-MN to the blood was noted after oral administration of titrated 2-MN. The distribution of the radioactivity in blood and lungs was at similar levels at all the time points analyzed [11] . Thus, it is very likely that 2-MN concentrations in the blood of animals exposed by inhalation are similar to 2-MN concentrations in the pulmonary parenchyma, which makes one conclude that the retention of 2-MN vapours in rat airways seems to be high. In the animals subjected to a single or repeated exposure to low-dose 2-MN, the trends of its elimination from blood were fairly similar. The half-lives for phase I and II in those experiments were alike despite the fact that blood 2-MN concentrations at the analyzed time points were different. The differences in blood 2-MN 
